Search / Trial NCT06229171

InTake Care: Development and Validation of an Innovative, Personalized Digital Health Solution for Medication Adherence Support in Cardiovascular Prevention

Launched by ISTITUTO AUXOLOGICO ITALIANO · Jan 26, 2024

Trial Information

Current as of October 03, 2024

Not yet recruiting

Keywords

Personalized Medicine

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Adult (\>18 years old) patients
  • * History of essential hypertension
  • * Treatment with at least one antihypertensive drug for which dedicated plasma essay is available
  • * wireless internet connection available at patients' home
  • * stable clinical conditions
  • * written informed consent
  • Exclusion Criteria:
  • * insufficient technological literacy to manage vocal assistant
  • * dementia or significant psychiatric disorders
  • * conditions significantly limiting vocal communication (deafness, significant speech disorders, poor knowledge of Italian language)
  • * pregnancy or breastfeeding
  • * active cancer (except basal cell skin carcinoma)
  • * upper limb amputation

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0